China Shineway Pharmaceutical Group Limited Receivables

China Shineway Pharmaceutical Group Limited posts a receivables of $850M as of June 2026. That compares with $1.3B in the prior-year period — down 33.3% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, China Shineway Pharmaceutical Group Limited's receivables was $1.3B. The latest reading is $850M — a 33.3% year-over-year decrease (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

Receivables is one piece of China Shineway Pharmaceutical Group Limited's financial statement story. At $850M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for CSWYF's receivables usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; China Shineway Pharmaceutical Group Limited's other metric pages and overview cover the third.